544694 — Accretion Nutraveda Share Price
- IN₹1.28bn
- IN₹1.32bn
- IN₹160.02m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 15.48 | ||
| Price to Tang. Book | 15.48 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 7.99 | ||
| EV to EBITDA | 35.55 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 37.67% | ||
| Return on Equity | 55.88% | ||
| Operating Margin | 21.76% | ||
Financial Summary
| Year End 31st Mar | Unit | 2021 | 2022 | 2023 | 2024 | 2025 | 2026E | 2027E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | n/a | 5.85 | 29.03 | 50.05 | 160.02 | n/a | n/a | 201.29% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | +192.91 | +217.9 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Accretion Nutraveda Limited is an India-based healthcare focused company. The Company is engaged in the manufacturing and sale of pharmaceutical products. It is engaged in the manufacturing of Ayurvedic and Nutraceutical products across multiple dosage forms, which include tablets, capsules, oral liquids, oral powders, external preparations, and oils. Its product portfolio includes tablets such as film-coated and chewable forms, intended for applications related to liver care, gynecological care, bone and joint health, and respiratory support. It also manufactures capsules directed towards liver detoxification, women’s health, and cognitive support. Its oral liquid products include syrups, suspensions, tonics, and traditional decoctions, formulated for paediatric and geriatric applications. It also produces traditional Ayurvedic powders, known as churans, for digestive health, medicated Ayurvedic oils used in musculoskeletal and dermatological treatments.
Directors
- Last Annual
- March 31st, 2025
- Last Interim
- September 30th, 2025
- Incorporated
- March 16th, 2021
- Public Since
- February 4th, 2026
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
Bombay Stock Exchange
- Shares in Issue
- 7,240,000

- Address
- 27 Xcelon Industrial Park-1, AHMEDABAD, 382213
- Web
- https://www.accretionnutraveda.com/
- Phone
- Auditors
- VS S B & Associates
Similar to 544694
Aayush Wellness
Bombay Stock Exchange
Achyut Healthcare
Bombay Stock Exchange
Adline Chem Lab
Bombay Stock Exchange
MPS Pharmaa
Bombay Stock Exchange
Albert David
Bombay Stock Exchange
FAQ
As of Today at 09:03 UTC, shares in Accretion Nutraveda are trading at IN₹176.70. This share price information is delayed by 15 minutes.
Shares in Accretion Nutraveda last closed at IN₹176.70 and the price had moved by over the past 365 days. In terms of relative price strength the Accretion Nutraveda share price has matched the S&P BSE 100 Index by over the past year.
There is no consensus recommendation for this security.
Find out moreAccretion Nutraveda does not currently pay a dividend.
Accretion Nutraveda does not currently pay a dividend.
Accretion Nutraveda does not currently pay a dividend.
To buy shares in Accretion Nutraveda you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of IN₹176.70, shares in Accretion Nutraveda had a market capitalisation of IN₹1.28bn.
Here are the trading details for Accretion Nutraveda:
- Country of listing: India
- Exchange: BSE
- Ticker Symbol: 544694
Based on an overall assessment of its quality, value and momentum Accretion Nutraveda is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Accretion Nutraveda. Over the past six months, its share price has matched the S&P BSE 100 Index by .
As of the last closing price of IN₹176.70, shares in Accretion Nutraveda were trading matched their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Accretion Nutraveda PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at IN₹176.70.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Accretion Nutraveda's directors





